1. Home
  2. KBH vs IRON Comparison

KBH vs IRON Comparison

Compare KBH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$56.86

Market Cap

3.6B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$79.21

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBH
IRON
Founded
1957
2017
Country
United States
United States
Employees
2384
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
KBH
IRON
Price
$56.86
$79.21
Analyst Decision
Hold
Strong Buy
Analyst Count
13
13
Target Price
$64.45
$108.85
AVG Volume (30 Days)
1.5M
648.0K
Earning Date
12-18-2025
11-06-2025
Dividend Yield
1.77%
N/A
EPS Growth
N/A
N/A
EPS
6.15
N/A
Revenue
$6,236,214,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.45
N/A
P/E Ratio
$9.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$48.90
$30.82
52 Week High
$72.64
$99.50

Technical Indicators

Market Signals
Indicator
KBH
IRON
Relative Strength Index (RSI) 36.33 36.31
Support Level $56.02 $76.24
Resistance Level $57.29 $80.32
Average True Range (ATR) 1.45 4.03
MACD -0.56 -1.17
Stochastic Oscillator 8.54 32.01

Price Performance

Historical Comparison
KBH
IRON

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: